Gene · 3913
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease. | Hepatol Commun | 2023 | 37756043 | PubTator, text mining | PubMed |
| Recent Development and Application of "Nanozyme" Artificial Enzymes-A Review. | Biomimetics (Basel) | 2023 | 37754197 | PubTator, text mining | PubMed |
| Hearing loss and vestibular schwannoma: new insights into Schwann cells implication. | Cell Death Dis | 2023 | 37741837 | PubTator, text mining | PubMed |
| Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium. | Mol Neurodegener | 2023 | 37735444 | PubTator, text mining | PubMed |
| Critical functions of extracellular matrix in brain metastasis seeding. | Cell Mol Life Sci | 2023 | 37728789 | PubTator, text mining | PubMed |
| Extracellular matrix-induced signaling pathways in mesenchymal stem/stromal cells. | Cell Commun Signal | 2023 | 37726815 | PubTator, text mining | PubMed |
| Dysregulation of core neurodevelopmental pathways-a common feature of cancers with perineural invasion. | Front Genet | 2023 | 37719704 | PubTator, text mining | PubMed |
| Focusing on the Native Matrix Proteins in Calcific Aortic Valve Stenosis. | JACC Basic Transl Sci | 2023 | 37719438 | PubTator, text mining | PubMed |
| Extracellular matrix turnover in salivary gland disorders and regenerative therapies: Obstacles and opportunities. | J Oral Biol Craniofac Res | 2023 | 37719063 | PubTator, text mining | PubMed |
| Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review. | Stem Cells Transl Med | 2023 | 37715961 | PubTator, text mining | PubMed |
| Challenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors. | Oncol Rev | 2023 | 37711860 | PubTator, text mining | PubMed |
| Skin substitutes as treatment for chronic wounds: current and future directions. | Front Med (Lausanne) | 2023 | 37711741 | PubTator, text mining | PubMed |
| Retinopathy as an initial sign of hereditary immunological diseases: report of six families and challenges in eye clinic. | Front Immunol | 2023 | 37711606 | PubTator, text mining | PubMed |
| Systematic Review of Clinical Characteristics and Genotype-Phenotype Correlation in LAMB2-Associated Disease. | Kidney Int Rep | 2023 | 37705905 | PubTator, text mining | PubMed |
| A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease. | Sci Transl Med | 2023 | 37703354 | PubTator, text mining | PubMed |
| The role of three-dimensional in vitro models in modelling the inflammatory microenvironment associated with obesity in breast cancer. | Breast Cancer Res | 2023 | 37697381 | PubTator, text mining | PubMed |
| Comparison of Amnion Membrane and Hyaluronic Acid in Gingival Recession Coverage and Gain in Clinical Attachment Level following Coronally Advanced Flap Procedure-A Clinical Study. | J Pharm Bioallied Sci | 2023 | 37694043 | PubTator, text mining | PubMed |
| Osteopathic Approach for Keloids and Hypertrophic Scars. | Cureus | 2023 | 37692181 | PubTator, text mining | PubMed |
| A rare cause of steroid-resistant nephrotic syndrome - a case report. | Cent Eur J Immunol | 2023 | 37692026 | PubTator, text mining | PubMed |
| ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer. | Front Immunol | 2023 | 37691929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/papers?page=16